Background P53 is the most widely investigated molecular marker in bladder cancer. We
aimed to review comprehensively the evidence for use of changes in P53 to predict bladder …

Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. It is more frequent
in men than in women. We review the main established/proposed factors, both …

Study objective: To evaluate whether consumption of chlorinated drinking water is
associated with bladder cancer. Design: A bibliographic search was conducted and the …

Expression of the activating CD94/NKG2C killer lectin-like receptor (KLR) specific for HLA-E
was analyzed in peripheral blood lymphocytes (PBLs) from healthy adult blood donors; the …

Background Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with
heterogeneous clinical outcomes. Several molecular classifications have been proposed …

Background Many reported associations between common genetic polymorphisms and
complex diseases have not been confirmed in subsequent studies. An exception could be …

Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease with widely
different outcomes. We performed a comprehensive transcriptional analysis of 460 early …

Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations,
characterized by the stabilization of β-catenin and constitutive transcription by the β …

The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized
by large biological heterogeneity with variable clinical outcomes. Here, we perform an …

Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological and genetic
levels. Tumor invasiveness (T) and grade (G) are the main factors associated with outcome …